3,515
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-κB signalling in rats

, , & ORCID Icon
Pages 119-126 | Received 03 Sep 2020, Accepted 13 Jan 2021, Published online: 04 Feb 2021

References

  • Chen L, Liu P, Feng X, Ma C. 2017. Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo. J Cell Mol Med. 21(12):3178–3189.
  • Chen YH, Lu S. 2020. Study on berberine, the active component of rhizoma coptidis and its biological function. China Feed. 10:5–7. Chinese.
  • Cheng Y, Regnier M. 2016. Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility. Arch Biochem Biophys. 601:11–21.
  • Chu M, Gao Y, Zhou B, Wu B, Wang J, Xu D. 2016. Circumferential strain can be used to detect lipopolysaccharide-induced myocardial dysfunction and predict the mortality of severe sepsis in mice. PLoS One. 11(5):e0155346.
  • Cirulis MM, Beesley SJ, Wilson EL, Stubben C, Olsen TD, Hirshberg EL, Smith LM, Lanspa MJ, Abraham TP, Grissom CK, et al. 2019. The peripheral blood transcriptome in septic cardiomyopathy: an observational, pilot study. Intensive Care Med Exp. 7:57.
  • de Pádua Lúcio K, Rabelo ACS, Araújo CM, Brandão GC, de Souza GHB, da Silva RG, de Souza DMS, Talvani A, Bezerra FS, Cruz Calsavara AJ, et al. 2018. Anti-inflammatory and antioxidant properties of black mulberry (Morus nigra L.) in a model of LPS-induced sepsis. Oxid Med Cell Longev. 2018:5048031.
  • Denk S, Perl M, Huber-Lang M. 2012. Damage- and pathogen-associated molecular patterns and alarmins: keys to sepsis? Eur Surg Res. 48(4):171–179.
  • Ehrman RR, Sullivan AN, Favot MJ, Sherwin RL, Reynolds CA, Abidov A, Levy PD. 2018. Pathophysiology, echocardiographic evaluation, biomarker findings, and prognostic implications of septic cardiomyopathy: a review of the literature. Crit Care. 22(1):112.
  • Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. 2011. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 52(4):427–431.
  • Gao M-y, Chen L, Yang L, Yu X, Kou J-p, Yu B-y. 2014. Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells. Pharmacol Rep. 66(3):480–484.
  • Gyongyosi M, Winkler J, Ramos I, Do QT, Firat H, McDonald K, Gonzalez A, Thum T, Diez J, Jaisser F, et al. 2017. Myocardial fibrosis: biomedical research from bench to bedside. Eur J Heart Fail. 19(2):177–191.
  • Hobai IA, Edgecomb J, LaBarge K, Colucci WS. 2015. Dysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathy. Shock. 43(1):3–15.
  • Jiang W, Kong L, Ni Q, Lu Y, Ding W, Liu G, Pu L, Tang W, Kong L. 2014. miR-146a ameliorates liver ischemia/reperfusion injury by suppressing IRAK1 and TRAF6. PLoS One. 9(7):e101530.
  • Kakihana Y, Ito T, Nakahara M, Yamaguchi K, Yasuda T. 2016. Sepsis-induced myocardial dysfunction: pathophysiology and management. J Intensive Care. 4:22.
  • Kimchi A, Ellrodt AG, Berman DS, Riedinger MS, Swan HJ, Murata GH. 1984. Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study. J Am Coll Cardiol. 4(5):945–951.
  • Lee D, Bae J, Kim YK, Gil M, Lee JY, Park CS, Lee KJ. 2013. Inhibitory effects of berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages. Biochem Biophys Res Commun. 431(3):506–511.
  • Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, Ho TY. 2007. Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res. 56(3):193–201.
  • Li H, Wang Y, Zhang H, Jia B, Wang D, Li H, Lu D, Qi R, Yan Y, Wang H. 2012. Yohimbine enhances protection of berberine against LPS-induced mouse lethality through multiple mechanisms. PLoS One. 7(12):e52863.
  • Lv X, Wang H. 2016. Pathophysiology of sepsis-induced myocardial dysfunction. Mil Med Res. 3:30.
  • Maeder M, Fehr T, Rickli H, Ammann P. 2006. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest. 129(5):1349–1366.
  • Martin L, Derwall M, Al Zoubi S, Zechendorf E, Reuter DA, Thiemermann C, Schuerholz T. 2019. The septic heart: current understanding of molecular mechanisms and clinical implications. Chest. 155(2):427–437.
  • Pan P, Wang X, Liu D. 2018. The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy. J Int Med Res. 46(6):2157–2169.
  • Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB. 2008. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 68(13):5370–5379.
  • Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. 1984. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 100(4):483–490.
  • Potz BA, Sellke FW, Abid MR. 2016. Endothelial ros and impaired myocardial oxygen consumption in sepsis-induced cardiac dysfunction. J Intensive Crit Care. 2:20.
  • Sanfilippo F, Orde S, Oliveri F, Scolletta S, Astuto M. 2019. The challenging diagnosis of septic cardiomyopathy. Chest. 156(3):635–636.
  • Sato R, Nasu M. 2015. A review of sepsis-induced cardiomyopathy. J Intensive Care. 3:48.
  • Sun H, Wu J. 2020. Research progress on pharmacological effects of berberine. J Xinxiang Med Univ. 37:91–95. Chinese.
  • Szostak R, Aube J, Szostak M. 2015. Determination of structures and energetics of small- and medium-sized one-carbon-bridged twisted amides using ab initio molecular orbital methods: implications for amidic resonance along the c-n rotational pathway. J Org Chem. 80(16):7905–7927.
  • Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, et al. 2012. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect. 18(Suppl 7):53–67.
  • Wang Z, Bu L, Yang P, Feng S, Xu F. 2019. Alleviation of sepsis-induced cardiac dysfunction by overexpression of Sestrin2 is associated with inhibition of p-S6K and activation of the p-AMPK pathway. Mol Med Rep. 20(3):2511–2518.
  • Wang Y, Zhang S. 2018. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. Biomed Pharmacother. 103:1287–1293.
  • Wu X, Xu W, Feng X, He Y, Liu X, Gao Y, Yang S, Shao Z, Yang C, Ye Z. 2015. TNF-a mediated inflammatory macrophage polarization contributes to the pathogenesis of steroid-induced osteonecrosis in mice. Int J Immunopathol Pharmacol. 28(3):351–361.